Addiction treatment drug maker Indivior said it had agreed to pay $385m to resolve the final lawsuit claims against it in the long-running Suboxone anti-trust case.
America's Department of Defense granted Chemring the majority of the approvals needed in order to proceed with the delivery of certain countermeasures.
St.James's Place announced the result of its previously announced review into its charging structure which was expected to come into effect in the back half of 2025.